Shuimu BioSciences

Successfully obtaining high-resolution 3D structures of biological macromolecules using cryo-electron microscopy (Cryo-EM), particularly through Single Particle Analysis (SPA), hinges significantly on the quality of your sample preparation. Preparing a sample that is pure, homogeneous, and appropriately concentrated is paramount for achieving meaningful results. This comprehensive guide, drawing insights from leading practices, outlines the critical steps involved in cryo em sample preparation and cryo em grid preparation.

Effective cryo em sample preparation minimizes issues such as particle aggregation, preferential orientation, and high background noise, which can otherwise hinder data collection and analysis. Whether you are working with proteins, viruses, or small molecules, mastering these steps is key to successful structural determination.

To learn more about advanced workflows and comprehensive support for your cryo-EM projects, visit https://shuimubio.com/.

Here are 10 essential steps for effective cryo em sample preparation:

Step 1: Define Your Target and Required Service

Before starting sample preparation, clearly identify the biological macromolecule you are working with (e.g., protein, protein complex, virus, small molecule, peptide) and the cryo-EM technique you intend to use (e.g., SPA, MicroED, Negative Staining, Cryo-Characterization). Different sample types and techniques have specific requirements for purity, concentration, volume, and buffer conditions. Understanding these requirements from the outset is crucial for successful cryo em sample preparation.

Step 2: Obtain High-Quality Target Material (Expression or Source)

For proteins and protein complexes, the process often begins with obtaining the target protein. This involves selecting an appropriate expression system. Common protein expression systems include E. coli, mammalian cells, insect cells, and cell-free systems. The choice of system depends on the protein type; for example, mammalian cells are preferred for therapeutic proteins, vaccines, and antibodies due to their ability to perform post-translational modifications similar to natural molecules, while E. coli is economical and fast, especially for small molecule proteins. Insect cells are characterized by high expression efficiency, and cell-free systems offer speed. Establishing a complete protein expression and purification platform minimizes variability and addresses challenges posed by difficult-to-express proteins.

Step 3: Purify Your Sample to High Purity

Purity is a critical factor in cryo em sample preparation. Protein samples, for instance, typically require a purity of ≥ 90%, often >95% for techniques like Negative Staining and Crystallography. Small molecules need purity > 95%. Various purification processes can be employed, such as affinity chromatography, ion-exchange chromatography, gel filtration, and reverse-phase HPLC (RP-HPLC). Gel filtration is specifically mentioned for achieving higher purity. Antibodies can be purified using Ni affinity columns. High purity is essential to avoid background noise and ensure that the collected data pertains specifically to the target molecule.

Step 4: Characterize and Assess Sample Quality & Homogeneity

Ensuring sample quality and homogeneity is a vital part of cryo em sample preparation. Techniques like SDS-PAGE, Western blot, and mass spectrometry can be used for protein quality control. Negative staining is widely used to quickly assess sample particle size, uniformity, oligomeric state, morphology, particle density, flexibility, integrity, conformation, and compositional heterogeneity at a lower cost, serving as a basis for further cryo-EM research. It's commonly used for assessing particle homogeneity in proteins like AAV, exosomes, membrane proteins, viruses, and soluble proteins. Samples should show high uniformity, ideally >90% after molecular sieving, with a single peak. For nanoparticle samples like AAV, liposomes, LNPs, and VLPs, Cryo-Characterization services utilizing AI systems like NanoSMART can automatically identify features like size distribution, roundness, and integrity, providing detailed reports.

Step 5: Optimize Sample Buffer Conditions and Concentration

The buffer composition and sample concentration significantly impact the outcome of cryo em sample preparation. Specific requirements are outlined for different sample types:

· Protein solution for SPA: Concentration ≥ 2mg/mL, volume ≥ 100ul. Buffer should minimize glycerol, salt ions (≤ 300mM), detergents, sucrose, and organic solvents. Buffer volume of 50~100mL is recommended.

· Small Molecules for SPA: Require information on molecular weight, formula, water solubility, dissolution buffer. Purity >95%. Need >10mg, soluble in DMSO or water to >100mM, or at least 1mM if poor water solubility. Provide affinity data (nanomolar level).

· Negative Staining: Concentration 0.01-0.02 mg/ml, volume 50ul-100ul (single use). Buffer should not contain polysaccharides, DMSO, glycerol, or other organic substances, with salt ion concentration below 300 mM. Send extra buffer (15-20ml, or 50-100ml for molecular sieve) for concentration exploration.

· Cryo-Characterization (Nanoparticles): Liposomes: 1mg/ml. Viruses (AAV): Suggested e13 power, at least 50μl/sample. LNP: Suggested concentration increase to around 10mg/ml; low concentration (e.g., 3mg/ml) may not enter the hole. Sugar content <10%.

· Crystallography: Soluble Protein/Antigen-Antibody: Purity >95%, concentration >10mg/ml, total amount >5mg or >10mg respectively. Small molecules for co-crystallization: Purity >95%, water solubility >10mM, DMSO >100mM, total amount >0.5mg.

· SPR: Protein Purity >90%, concentration >200ug/ml, minimum 20 ug per experiment. Small Molecule Purity >90%, concentration >10mM, minimum 500ug, dissolved in 100% DMSO or water. Sample must not contain glycerol, imidazole, trehalose, etc..

· BLI: Protein Purity not less than 90%. Protein concentration 0.1-10μM, volume not less than 50μL. Recommend PBS buffer (pH 7.2 - 7.4).

· ELISA: Processed samples containing target protein. Volume not less than 100μL.

Reducing modifications like glycosylation or phosphorylation for SPA can also be beneficial.

Step 6: Prepare Sample Aliquots and Minimize Freeze-Thaw Cycles

Repeated freeze-thaw cycles can damage samples and render them unusable. It is strongly recommended to aliquot samples after preparation to avoid this. Using freshly prepared samples is also advised for optimal results.

Step 7: Select and Prepare the Cryo-EM Grid

Cryo em grid preparation is a crucial step where the sample is applied to a grid before being vitrified. Traditional support grids can face issues like gas-liquid interface absorption, severe preferred orientation, high sample concentration thresholds, and significant background noise. To overcome these challenges, specialized grids like graphene support grids (GraFuture™, including GO and RGO) have been developed. These are suitable for samples with small protein molecular weight, low concentration, strong background noise, and sensitivity to the air-water interface. Shuimu offers these advanced graphene grids. Equipment like the Vitrobot is used in the closed-loop management of the experimental process, likely referring to automated sample application and blotting onto the grid before freezing. Dual-Affinity Graphene Sheets are also mentioned in case studies. The choice of grid can impact the success of data collection, especially for challenging samples.

Step 8: Vitrify the Sample on the Grid

Once the sample is applied to the appropriate grid, it must be rapidly frozen, a process called vitrification. This is a critical step in cryo em sample preparation that aims to preserve the biological sample in a near-native, amorphous ice state, preventing the formation of ice crystals which would damage the structure. Sample freezing and data collection are integral parts of the SPA workflow. This step typically uses automated plunge freezers like the Vitrobot.

Step 9: Handle and Transport Cryo-Samples and Grids Appropriately

After vitrification, the cryo-samples (vitrified samples on grids) must be kept at ultra-low temperatures to maintain their frozen state. Cryo em grid preparation isn't complete until the grid is safely transported to the microscope. Samples should be sent frozen with dry ice and should not be thawed in advance. Cryo-samples should be delivered to the Cryo-EM Center at least 1 working day in advance of instrument use. Grids can be transported via liquid nitrogen tanks, and clips for grids are provided.

Step 10: Coordinate Sample Submission and Logistics

Efficient communication and logistics are essential. Notify the operations manager or sales colleague in advance (often 3 working days) for fresh sample delivery, shipping arrangements, or timely testing coordination. For samples prepared on the Shuimu EM platform, machine time should be reserved in advance, providing paper sample preparation conditions with the sample. It is also necessary to synchronize the sample loading order at least 1 working day in advance. Clearly labeling samples with name, type, concentration, volume, storage conditions, sending unit, and contact information is crucial for accurate processing. For data collection, preparing a hard drive for data copying, with a reference size of 4T/day, is required.

By following these essential steps in cryo em sample preparation and cryo em grid preparation, researchers can significantly increase their chances of obtaining high-quality data suitable for high-resolution structural determination.

Shuimu BioSciences offers comprehensive "One-Stop" solutions, combining protein preparation and analysis platforms with state-of-the-art cryo-EM facilities and experienced scientists. Their expertise, cutting-edge equipment like 300 kV instruments (2 in Beijing, 6 in Hangzhou), and AI-driven platforms like SMART and NanoSMART are designed to support researchers throughout this complex process, from gene sequences to high-resolution 3D structures. They have extensive experience with various sample types, including difficult-to-express membrane proteins, antigen-antibody complexes, and viral particles.

For detailed information on their services, sample submission, and how their expertise can benefit your structural biology research, please visit https://shuimubio.com/.

Contact us

See Unseeable.
Drug Undruggable.

Founded in 2017, Shuimu BioSciences aims to bring the power of cryo-EM to innovative therapeutics developers.

Contacts

1 Broadway 5th floor, Cambridge, MA 02142, United States+1 (650) 680 9383

Hi@shuimubio.com

Copyright © 2026 Shuimu Biosciences Ltd.
京ICP备2020035593号